|
|
||||||||

*
Division of Immunology, Allergy and Infectious Diseases, Department of Dermatology, University of Vienna Medical School, Vienna, Austria; and
Research Institute of Molecular Pathology, Vienna, Austria
Transfection of a variety of tumor lines with the IL-2 gene
strongly reduces their tumorigenic potential when applied to either
euthymic or athymic animals. To elucidate the mechanisms underlying
this phenomenon, we inoculated IL-2-transfected M-3D melanoma
(M-3D-IL-2) cells into DBA/2 mice immunosuppressed by
-irradiation.
Animals thus treated developed pigmented tumors, suggesting that IL-2
transfection of melanoma cells, instead of altering their neoplastic
growth properties, renders them capable of evoking a tumoricidal host
response. To define the critical effector cell, we injected M-3D-IL-2
and, for control purposes, nontransfected M-3D cells into DBA/2
recipients and analyzed the injection site. We found that 1)
IL-2-expressing M-3D cells induce a much stronger inflammatory reaction
than wild-type cells, 2) in both instances the infiltrate consists
mainly of macrophages (4060%) and granulocytes (3040%), and 3)
only the infiltrate of M-3D-IL-2 cell deposits contains a minor
fraction of NK cells (
12%). When we reconstituted sublethally
irradiated animals with various leukocyte subsets, we found that
unfractionated as well as macrophage-depleted peritoneal lavage cells
but not NK cell-depleted peritoneal lavage cells were able to suppress
the growth of IL-2-expressing M-3D cells. In vivo leukocyte depletion
experiments showed that the NK cell-depleting asialo-GM1 antiserum, but
not anti-macrophage and/or anti-granulocyte reagents, restored
the tumorigenicity of M-3D-IL-2 cells. Our results indicate that the
inflammatory tissue response evoked by IL-2-transfected cancer cells
includes the attraction and/or activation of NK cells and that, in the
experimental system used, these cells are critically needed for
successfully controlling cancer growth in vivo.
This article has been cited by other articles:
![]() |
A. Schneeberger, P. Luhrs, R. Kutil, P. Steinlein, H. Schild, W. Schmidt, and G. Stingl Granulocyte-Macrophage Colony-Stimulating Factor-Based Melanoma Cell Vaccines Immunize Syngeneic and Allogeneic Recipients via Host Dendritic Cells J. Immunol., November 15, 2003; 171(10): 5180 - 5187. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |